Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS.
Smoking is the major contributor of lung cancer (LC), which accounts for millions of death. This study focused on the correlation between the proteomic profiling of LC patients, and healthy nonsmokers and smokers. Pattern-based peptide profiling of 186 plasma samples was performed through reversed-phase chromatography-18 magnetic bead fractionation coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis and resulted data were evaluated statistically by ClinProTool. Marker peaks at m/z 1760, 5773, 5851, 2940, and 7172 were found with an excellent statistical figure. Selected marker peaks can be served as a differentiated tool of LC patients with high sensitivity and specificity.